3-Weekly Paclitaxel-Carboplatin With Radical Radiation for Stage III NSCLC – An Option During COVID-19 Pandemic

PURPOSE/OBJECTIVE(S): The optimal choice and schedule of chemotherapy (CT) given concurrently with radiation (RT) for primary treatment of stage III unresectable non-small cell lung cancer (NSCLC) remain debatable. 3-weekly paclitaxel-carboplatin (PC) is a convenient schedule but not well studied. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, H.C.Y., Lim, M.Y., Cheng, A.C.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
2947
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536220/
http://dx.doi.org/10.1016/j.ijrobp.2021.07.1284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536220/
http://dx.doi.org/10.1016/j.ijrobp.2021.07.1284

Ejemplares similares